Abstract
Quorum sensing signal molecules (QSSMs) from the bacterium Pseudomonas aeruginosa control bacterial population density and the expression of virulence determinants. Coincidentally, and possibly to allow this pathogen to gain a foothold in the human body, certain signal molecules also downregulate immunological responses in an apparently T-helper 1-selective manner, which would suggest their application as therapeutics to some autoimmune diseases. In the present paper, experiments are described that indicate that one particular signal molecule, a synthetic N-(3-oxododecanoyl)-L-homoserine lactone, can be used to alleviate insulitis and diabetes in non-obese diabetic (NOD) mice, suggesting that bacterial signal molecules may represent a novel source of immune modulatory compounds for the treatment of type 1 diabetes, which afflicts more than 2 million individuals in Europe and North America.
Original language | English |
---|---|
Pages (from-to) | 119-122 |
Number of pages | 3 |
Journal | Acta Diabetologica |
Volume | 42 |
Issue number | 3 |
DOIs | |
Publication status | Published - Oct 2005 |
Keywords
- Autoimmunity
- Mononuclear leucocytes
- Pancreas
- Therapeutics